ArriVent BioPharma is developing a treatment for non-small cell lung cancer. Click here to read more about AVBP stock and ...
UW-Madison researchers created a colony of bat skin cells to mimic hibernation and study how the fungus infects cells and spreads.
Firmonertinib demonstrated efficacy and safety in patients with EGFR PACC-mutated non–small cell lung cancer.
Verywell Health on MSN1y
Will Cancer Ever Be Cured?Either way, the many types cancer and the differences in those living with them will significantly factor into this effort, meaning there can't be a one-size-fits-all approach to curing cancer. Today, ...
Detailed results from the TROPION-Lung01 Phase III trial showed a clinically meaningful trend toward improving overall survival (OS) with datopotamab ...
将Gefitinib与LXH-3-71通过不同的化学连接子结合，筛选出最有效的EGFR降解剂——化合物37。随后，合成了针对CDK4的TPD分子45。实验结果显示，这些TPD分子的降解效果可通过MG-132或DDB1敲低抑制 ...
New longer-term data from the MARIPOSA study confirm superior outcomes of amivantamab plus lazertinib regimen compared to osimertinib monotherapy as first-line therapy1 Results from an interim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback